Genomics and multi-omics companies develop technologies, services and analytical platforms that help researchers and clinicians understand biological systems at the DNA, RNA, protein and cellular level. The field underpins advances in precision medicine, drug discovery, diagnostics, agriculture and biotechnology.
This category includes companies working on:
Browse 146 UK genomics and multi-omics companies below.
Applied genetics and genomics services and distribution for DNA testing
Biosecure ID is a contract research organisation providing professional services and integrated workflow solutions for applied genetics and genomics testing. The company supports…
AI-powered cell simulation platform targeting ageing and age-driven diseases
Shift Bioscience is a biotechnology company developing an AI-powered virtual cell platform to identify novel therapeutic targets for cellular rejuvenation. Its proprietary…
Rapid airborne DNA sequencing service for pathogen detection and biosecurity
Agnos Biosciences is a deep tech company commercialising AirSeq, a rapid DNA air sequencing technology for the detection and quantification of airborne biological material. AirSeq…
National genomics research and NHS whole genome sequencing
Genomics England is a government-owned organisation that partners with the NHS to deliver whole genome sequencing diagnostics and advance genomic medicine in the UK. It operates…
BBSRC-funded genomics and bioinformatics research institute
The Earlham Institute is a BBSRC-funded life science research institute based at Norwich Research Park, specialising in genomics, bioinformatics, single-cell research and…
Point-of-care pharmacogenetic testing platform for emergency healthcare
Genedrive is a molecular diagnostics company developing point-of-need pharmacogenetic tests that identify genetic variants to guide safer, more personalised medicine decisions in…
Inkjet microarray printing instruments and contract array services
Arrayjet is a manufacturer of inkjet-based microarray printing instruments and a provider of contract array research and manufacturing services. The company's patented non-contact…
Enzyme-free multiplex RNA diagnostics for rapid clinical decisions
Cambridge Nucleomics is a biotechnology company developing a proprietary nanopore-based platform for rapid, high-multiplexed detection of nucleic acid biomarkers. Its enzyme-free…
Global leader in next-generation sequencing and genomic analysis
Illumina is a US-headquartered life science company and the dominant provider of next-generation sequencing platforms and array-based genotyping tools. Its UK operations are based…
Dark genome platform identifying first-in-class targets for autoimmune disease
Nucleome Therapeutics is a drug discovery company using 3D genome mapping to identify therapeutic targets encoded in the non-coding regions of the human genome. Its platform…
AI platform combining retinal imaging and genomics for inherited eye disease diagnosis
Eye2Gene is an AI-powered precision ophthalmology platform combining retinal imaging with genomic analysis to accelerate diagnosis of inherited retinal diseases. Using a neural…
Predictive genetic tests for cancer and cardiovascular disease
GENinCode is a clinical-stage diagnostics company developing polygenic risk assessment tests for cardiovascular disease and ovarian cancer. Its portfolio includes CE-marked…